Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10681	Companies
228020	Keywords
156520	Articles
120880	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 09/29/2025 at 06:00, 9 months 6 days ago

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
Onco-Innovations collaborates with Nucro-Technics for preclinical drug development services focusing on PNKP Technology. Nucro-Technics initiates lab work under IND enabling program with advanced analytical methods based on LC-MS

Preclinical Onco-Innovations PNKP Technology Nucro-Technics Analytical Methods
BRIEF

published on 09/22/2025 at 23:05, 9 months 13 days ago

Onco-Innovations Appoints Dr. Michael Lock to Advisory Board

Cancer Research Onco-Innovations PNKP Inhibitor Clinical Advisory Board Dr. Michael Lock
BRIEF

published on 09/22/2025 at 23:05, 9 months 13 days ago

Onco-Innovations nomme le Dr Michael Lock au conseil consultatif

Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Dr Michael Lock Conseil Consultatif Clinique
PRESS RELEASE

published on 09/22/2025 at 23:00, 9 months 13 days ago

Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
Onco-Innovations appoints Dr. Michael Lock, an expert in oncology and clinical trial design, to its Advisory Board. The company also grants RSUs to key personnel

Cancer Research RSUs Onco-Innovations Dr. Michael Lock Clinical Trial Design
BRIEF

published on 09/20/2025 at 00:05, 9 months 16 days ago

Onco-Innovations Initiates Nanoparticle Manufacturing with Dalton Pharma

Cancer Treatment Preclinical Studies Nanoparticle Manufacturing Onco-Innovations Dalton Pharma
BRIEF

published on 09/20/2025 at 00:05, 9 months 16 days ago

Onco-Innovations lance la fabrication de nanoparticules avec Dalton Pharma

Traitement Du Cancer Etudes Précliniques Fabrication De Nanoparticules Onco-Innovations Dalton Pharma
PRESS RELEASE

published on 09/20/2025 at 00:00, 9 months 16 days ago

Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies
Onco-Innovations announces manufacturing of nanoparticle formulation by Dalton Pharma Services to advance preclinical studies, enhancing clinical readiness in cancer research

Cancer Research Preclinical Studies Onco-Innovations Nanoparticle Formulation Dalton Pharma Services
BRIEF

published on 09/13/2025 at 00:05, 9 months 23 days ago

Onco-Innovations animera un forum clé sur l'oncologie et la médecine de précision

Oncologie Confiance Numérique Médecine De Précision L'IA Dans Le Secteur De La Santé Innovation En Matière De Données
BRIEF

published on 09/13/2025 at 00:05, 9 months 23 days ago

Onco-Innovations to Lead Key Oncology Forum on Precision Medicine

Oncology Precision Medicine Digital Trust AI In Healthcare Data Innovation
PRESS RELEASE

published on 09/13/2025 at 00:00, 9 months 23 days ago

Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care
Onco-Innovations to lead CRC Catalysts roundtable on data innovation and digital trust in oncology, advancing precision medicine. Enhanced by expert speakers, including Dr. Paul Arora

Precision Medicine Digital Trust Onco-Innovations Data Innovation CRC Catalysts

Accesswire

Published on 07/03/2026 at 23:00, 2 days 2 hours ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 2 days 2 hours ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 2 days 4 hours ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 2 days 6 hours ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 2 days 12 hours ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/05/2026 at 13:45, 12 hours 12 minutes ago

XPPen renforce son engagement en faveur de l’animation grâce à son partenariat avec la Résidence du Festival d’Annecy 2026 et sa présence au MIFA
Published on 07/05/2026 at 13:45, 12 hours 12 minutes ago

XPPen Strengthens Its Commitment to Animation with 2026 Annecy Festival Residency Partnership and MIFA Showcase
Published on 07/04/2026 at 17:35, 1 day 8 hours ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 1 day 14 hours ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 1 day 16 hours ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love

Les Echos

Published on 07/03/2026 at 21:49, 2 days 4 hours ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 2 days 4 hours ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 2 days 7 hours ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 2 days 7 hours ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 2 days 7 hours ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE